Eculizumab Dosing Regimen in Atypical HUS: Possibilities for Individualized Treatment-Reference-Cited by-同舟云学术

Eculizumab Dosing Regimen in Atypical HUS: Possibilities for Individualized Treatment

Published:2017-05-26 Issue:4 Volume:102 Page:671-678
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Volokhina E¹²,Wijnsma K¹,van der Molen R²,Roeleveld N¹³,van der Velden T¹,Goertz J²,Sweep F²,Brüggemann RJ⁴,Wetzels J⁵,van de Kar N¹,van den Heuvel L¹²⁶

Affiliation:

1. Department of Pediatric Nephrology; Amalia Children's Hospital, Radboud University Medical Center; Nijmegen The Netherlands

2. Department of Laboratory Medicine; Radboud University Medical Center; Nijmegen The Netherlands

3. Department of Health Evidence; Radboud University Medical Center; Nijmegen The Netherlands

4. Department of Pharmacy; Radboud University Medical Center; Nijmegen The Netherlands

5. Department of Nephrology; Radboud University Medical Center; Nijmegen The Netherlands

6. Department of Pediatrics; University Hospitals Leuven; Leuven Belgium

Funder

Nierstichting

European Renal Association - European Dialysis and Transplantation Association

European Society for Pediatric Nephrology

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference48 articles.

1. Atypical hemolytic-uremic syndrome;Noris;N. Engl. J. Med.,2009

2. Atypical hemolytic uremic syndrome;Loirat;Orphanet. J. Rare Dis.,2011

3. A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome;Westra;Neth. J. Med.,2012

4. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults;Fremeaux-Bacchi;Clin. J. Am. Soc. Nephrol.,2013

5. Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab;Verhave;Nephrol. Dial. Transplant,2014

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-C5 monoclonal antibody treatment showing pathological resolution of complement-mediated atypical hemolytic uremic syndrome: a case report;BMC Nephrology;2024-07-15

2. Clinical presentation and management of atypical hemolytic uremic syndrome in Latin America: a narrative review of the literature;Expert Review of Hematology;2024-06-12

3. Complement Blockade, a New Therapeutic Approach in Malignant Hypertension;Internal Medicine;2024-03-01

4. Eculizumab dose tapering should take into account the nonlinearity of its pharmacokinetics;British Journal of Clinical Pharmacology;2024-02-19

5. Beyond Population‐Level Targets for Drug Concentrations: Precision Dosing Needs Individual‐Level Targets that Include Superior Biomarkers of Drug Responses;Clinical Pharmacology & Therapeutics;2024-02-08